Page last updated: 2024-12-08
heptaminol amp amidate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
heptaminol AMP amidate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 162816 |
| MeSH ID | M0152547 |
Synonyms (18)
| Synonym |
|---|
| 57249-13-5 |
| heptaminol amp amidate |
| einecs 260-650-8 |
| unii-j6yii057a9 |
| j6yii057a9 , |
| heptaminol 5'-adenylate |
| heptaminol amp conjugate |
| adenosine 5'-monophosphate, compound with 6-amino-2-methylheptan-2-ol (1:1) |
| heptaminol adenosine monophosphate amidate |
| 6-amino-2-methylheptan-2-ol--9-(5-o-phosphonopentofuranosyl)-9h-purin-6-amine (1/1) |
| DTXSID50972743 |
| Q27281281 |
| 6-amino-2-methylheptan-2-ol;[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate |
| heptaminol adenosine phosphate [who-dd] |
| heptaminol adenosine phosphate |
| 2-heptanol, 6-amino-2-methyl-, 5'-adenylate (1:1) (salt) |
| 5'-amp heptaminol salt |
| heptaminol 5'-adenylate [mi] |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.15
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.15) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (12.50%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||